Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 62 Total
TBIO - Telesis Bio Inc - Stock Price Chart
TickerTBIO [NASD]
CompanyTelesis Bio Inc
CountryUSA
IndustryMedical Devices
Market Cap9.18MEPS (ttm)-1.64
P/E-EPS this Y52.44%
Forward P/E-EPS next Y25.64%
PEG-EPS past 5Y-55.07%
P/S0.33EPS next 5Y-
P/B38.51EPS Q/Q-121.26%
Dividend-Sales Q/Q-26.32%
Insider Own71.16%Inst Own4.34%
Insider Trans0.00%Inst Trans-12.74%
Short Float1.21%EarningsMar 28/a
Analyst Recom1.67Target Price4.00
Avg Volume765.80K52W Range0.30 - 3.01
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
GRI - GRI Bio Inc - Stock Price Chart
TickerGRI [NASD]
CompanyGRI Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap1.54MEPS (ttm)-63.58
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y26.64%
P/S-EPS next 5Y-
P/B1.02EPS Q/Q87.41%
Dividend-Sales Q/Q-
Insider Own5.82%Inst Own0.73%
Insider Trans0.00%Inst Trans7.98%
Short Float0.51%EarningsApr 01/b
Analyst Recom1.00Target Price2520.00
Avg Volume324.87K52W Range0.40 - 53.90
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.
ALZN - Alzamend Neuro Inc - Stock Price Chart
TickerALZN [NASD]
CompanyAlzamend Neuro Inc
CountryUSA
IndustryBiotechnology
Market Cap4.26MEPS (ttm)-1.87
P/E-EPS this Y35.56%
Forward P/E-EPS next Y0.34%
PEG-EPS past 5Y-69.45%
P/S-EPS next 5Y-
P/B-EPS Q/Q54.40%
Dividend-Sales Q/Q-
Insider Own29.68%Inst Own5.45%
Insider Trans0.45%Inst Trans-
Short Float0.30%Earnings-
Analyst Recom2.00Target Price21.00
Avg Volume57.05K52W Range0.65 - 11.91
Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company, which focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AULT MILTON C IIIDirectorApr 19 '24Buy0.691,000688771,699Apr 23 08:00 PM
AULT MILTON C IIIDirectorApr 01 '24Buy0.91334304770,699Apr 03 05:00 PM
AULT MILTON C IIIDirectorJan 05 '24Buy1.025,0005,092768,365Jan 09 04:30 PM
AULT MILTON C IIIDirectorJan 05 '24Buy1.062,0002,127770,365Apr 01 04:30 PM
AULT MILTON C III10% OwnerDec 26 '23Buy0.9050045026,032Dec 27 04:30 PM
KYTX - Kyverna Therapeutics Inc. - Stock Price Chart
TickerKYTX [NASD]
CompanyKyverna Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap581.47MEPS (ttm)-
P/E-EPS this Y96.35%
Forward P/E-EPS next Y-22.14%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own29.61%Inst Own6.51%
Insider Trans19.27%Inst Trans-
Short Float5.13%EarningsMar 26/a
Analyst Recom1.00Target Price42.75
Avg Volume499.93K52W Range13.75 - 35.06
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 05:48 PM
Northpond Ventures III GP, LLCFormer 10% OwnerFeb 12 '24Buy22.00450,0009,900,000450,000Feb 12 05:51 PM
Bain Capital Life Sciences Inv10% OwnerFeb 12 '24Buy22.00450,0009,900,0003,163,868Feb 14 05:26 PM
Vida Ventures, LLC10% OwnerFeb 12 '24Buy22.00253,1365,568,992252,553Feb 14 07:04 PM
LINK - Interlink Electronics - Stock Price Chart
TickerLINK [NASD]
CompanyInterlink Electronics
CountryUSA
IndustryElectronic Components
Market Cap43.58MEPS (ttm)-0.06
P/E-EPS this Y-237.50%
Forward P/E-EPS next Y72.22%
PEG-EPS past 5Y-
P/S3.13EPS next 5Y-
P/B5.02EPS Q/Q-128.02%
Dividend-Sales Q/Q119.62%
Insider Own98.48%Inst Own0.64%
Insider Trans0.00%Inst Trans11.29%
Short Float3.07%EarningsMar 21/b
Analyst Recom1.00Target Price14.00
Avg Volume7.57K52W Range4.70 - 11.49
Interlink Electronics, Inc. engages in the design, development, manufacture, and sale of force sensing technology solutions. Its products include force sensing, position sensing and mouse pointing & touchpad. The company was founded on February 27, 1985 and is headquartered in Irvine, CA.
CERO - CERo Therapeutics Holdings Inc. - Stock Price Chart
TickerCERO [NASD]
CompanyCERo Therapeutics Holdings Inc.
CountryUSA
IndustryBiotechnology
Market Cap18.99MEPS (ttm)-0.38
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-16.75%
Dividend-Sales Q/Q-
Insider Own53.21%Inst Own5.81%
Insider Trans0.00%Inst Trans6.17%
Short Float0.39%Earnings-
Analyst Recom-Target Price-
Avg Volume1.12M52W Range1.30 - 12.80
CERo Therapeutics Holdings, Inc. is a blank check company, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
TWI - Titan International, Inc. - Stock Price Chart
TickerTWI [NYSE, RUT]
CompanyTitan International, Inc.
CountryUSA
IndustryFarm & Heavy Construction Machinery
Market Cap647.81MEPS (ttm)0.88
P/E10.09EPS this Y-22.01%
Forward P/E6.05EPS next Y18.55%
PEG0.40EPS past 5Y80.77%
P/S0.37EPS next 5Y25.00%
P/B1.03EPS Q/Q-72.02%
Dividend-Sales Q/Q-12.11%
Insider Own32.30%Inst Own61.25%
Insider Trans-0.01%Inst Trans1.29%
Short Float4.83%EarningsMay 01/a
Analyst Recom3.00Target Price19.00
Avg Volume348.84K52W Range9.03 - 15.33
Titan International, Inc. is a holding company engaged in the manufacture of wheels, tires, and undercarriage industrial. It operates through the following segments: Agricultural, Earthmoving and Construction, and Consumer. The Agricultural segment manufactures rims, wheels, and tires for use in various agricultural and forestry equipment, including tractors, combines, skidders, plows, planters, and irrigation equipment. The Earthmoving and Construction segment produces rims, wheels, and tires for various types of off-the-road earthmoving, mining, military and construction equipment, including skid steers, aerial lifts, cranes, graders and levelers, scrapers, self-propelled shovel loaders, articulated dump trucks, load transporters, haul trucks, and backhoe loaders, crawler tractors, lattice cranes, shovels, and hydraulic excavators. The Consumer segment manufactures truck tires in Latin America and light truck tires in Russia and offers select products for turf and golf cart applications. The company was founded by John A. Stillwell in 1890 and is headquartered in West Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eheli AnthonyVP, Chief Accounting OfficerMar 25 '24Sale12.422,50031,05052,918Mar 26 04:34 PM
Guinn Max ADirectorSep 18 '23Sale12.4918,402229,841132,379Sep 18 04:56 PM
Guinn Max ADirectorSep 15 '23Sale12.601,59820,135150,781Sep 18 04:56 PM
Guinn Max ADirectorSep 01 '23Sale12.9729,650384,560152,379Sep 05 04:36 PM
ODV - Osisko Development Corp - Stock Price Chart
TickerODV [NYSE]
CompanyOsisko Development Corp
CountryCanada
IndustryGold
Market Cap148.89MEPS (ttm)-1.61
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y43.17%
P/S6.34EPS next 5Y-
P/B0.34EPS Q/Q-90.73%
Dividend-Sales Q/Q-64.19%
Insider Own40.15%Inst Own16.75%
Insider Trans0.00%Inst Trans-
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume97.55K52W Range1.82 - 5.40
Osisko Development Corp. engages in the acquisition and exploration of mineral properties. It operates through the following projects. Cariboo, San Antonio, James Bay properties, Guerrero properties, and mineral reserve and resources. The company was founded on November 25, 2020 and is headquartered in Montreal, Canada.
KITT - Nauticus Robotics Inc - Stock Price Chart
TickerKITT [NASD]
CompanyNauticus Robotics Inc
CountryUSA
IndustryAerospace & Defense
Market Cap10.68MEPS (ttm)-1.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.05EPS next 5Y-
P/B-EPS Q/Q12.46%
Dividend-Sales Q/Q-64.33%
Insider Own70.26%Inst Own10.84%
Insider Trans-0.68%Inst Trans-75.31%
Short Float1.24%EarningsApr 10/b
Analyst Recom1.00Target Price10.00
Avg Volume1.66M52W Range0.18 - 2.55
Nauticus Robotics, Inc. engages in the development of ocean robots that are controlled through an AI-driven cloud software platform which enables a sliding scale spectrum of autonomous operations. It offers an aquanaut, hydronaut, argonaut, ToolKITT, and olympic arm. The company was founded by Nicolaus Adam Radford and Reginald Bruce Berka on November 24, 2021 and is headquartered in Webster, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLORES WILLIAMDirectorApr 15 '24Buy0.2229,7566,546100,000Apr 15 05:11 PM
FLORES WILLIAMDirectorApr 12 '24Buy0.2370,24416,15670,244Apr 15 05:11 PM
GIBSON JOHN W JRInterim CEOMar 13 '24Sale0.19352,47566,970615,305Mar 15 07:56 PM
Radford NicolausChief Executive OfficerJan 02 '24Sale0.6419,66712,5873,024,921Jan 03 09:44 PM
Bohan Donnelly A.Chief Operating OfficerJan 02 '24Sale0.6418,35711,748117,518Jan 03 09:44 PM
LUXH - LuxUrban Hotels Inc - Stock Price Chart
TickerLUXH [NASD]
CompanyLuxUrban Hotels Inc
CountryUSA
IndustryLodging
Market Cap31.46MEPS (ttm)-2.15
P/E-EPS this Y595.59%
Forward P/E2.71EPS next Y311.11%
PEG-EPS past 5Y-227.20%
P/S0.28EPS next 5Y30.00%
P/B-EPS Q/Q-356.48%
Dividend-Sales Q/Q112.47%
Insider Own75.61%Inst Own15.68%
Insider Trans-0.30%Inst Trans157.88%
Short Float24.98%EarningsApr 15/b
Analyst Recom1.67Target Price5.00
Avg Volume455.73K52W Range0.73 - 6.88
LuxUrban Hotels Inc. engages in the acquisition and management of hotel units. The company was founded on December 13, 2019 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ferdinand BrianChairman & Co-CEODec 13 '23Buy4.5625,000114,050225,825Dec 14 08:30 AM
Ferdinand BrianChairman & Co-CEODec 01 '23Sale4.4514,21963,27515,347,917Dec 04 07:00 AM
Ferdinand BrianChairman & Co-CEONov 30 '23Sale4.4662,000276,52015,362,136Dec 04 07:00 AM
Ferdinand BrianChairman & Co-CEONov 22 '23Sale5.216,55634,15715,424,136Nov 24 05:13 PM
Ferdinand BrianChairman & Co-CEONov 21 '23Sale5.1038,277195,21315,430,692Nov 24 05:13 PM
1234567